Article
FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders.
Neurology - 29 Nov 2016
Lehtonen Jenni M, Forsström Saara, Bottani Emanuela, Viscomi Carlo, Baris Olivier R, Isoniemi Helena, Höckerstedt Krister, Österlund Pia, Hurme Mikko, Jylhävä Juulia, Leppä Sirpa, Markkula Ritva, Heliö Tiina, Mombelli Giuliana, Uusimaa Johanna, Laaksonen Reijo, Laaksovirta Hannu, Auranen Mari, Zeviani Massimo, Smeitink Jan, Wiesner Rudolf J, Nakada Kazuto, Isohanni Pirjo, Suomalainen Anu
Abstract excerpt
OBJECTIVE: To validate new mitochondrial myopathy serum biomarkers for diagnostic use. METHODS: We analyzed serum FGF21 (S-FGF21) and GDF15 from patients with (1) mitochondrial diseases and (2) nonmitochondrial disorders partially overlapping with mitochondrial disorder phenotypes. We (3) did a meta-analysis of S-FGF21 in mitochondrial disease and (4) analyzed S-Fgf21 and skeletal muscle Fgf21 expression in 6...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
